https://pubmed.ncbi.nlm.nih.gov/33189582/ Originally published by: Trends Parasitol. Author: Martin, et al. Date: 1/1/2021 Categories: Integrative Therapies,Treatment,Ivermectin
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
https://www.covidstrategies.org/comparative-efficacy-and-safety-of-pharmacological-interventions-for-the-treatment-of-covid-19-a-systematic-review-and-network-meta-analysis/https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003501#pmed-1003501-g003 Originally published by: plos med Author: Min Seo Kim ,Min Ho An ,Won Jun Kim,Tae-Ho Hwang Date: 12/30/2020 Categories: Integrative...
EVMS Critical Care COVID-19 Protocol from 12/27/20
https://www.covidstrategies.org/evms-critical-care-covid-19-protocol-from-12-27-20/https://www.evms.edu/media/evms_public/departments/internal_medicine/Marik_Critical_Care_COVID-19_Protocol.pdf Originally published by: FLCCC Author: Dr. Paul Marik Date: 12/27/2020 Categories: Prevention,Integrative Therapies,Treatment,Ivermectin
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
https://www.covidstrategies.org/review-of-the-emerging-evidence-demonstrating-the-efficacy-of-ivermectin-in-the-prophylaxis-and-treatment-of-covid-19/https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-Integrative Therapies,Treatment-of-COVID-19.pdf Originally published by: FLCCC Author: Pierre Kory, MD, et al. Date: 12/18/2020 Categories: Prevention,Integrative...
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
https://www.covidstrategies.org/fda-approved-drugs-with-pharmacotherapeutic-potential-for-sars-cov-2-covid-19-therapy/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362818/ Originally published by: Science Direct Author: Drożdżal S, Rosik J, Lechowicz K, et al. Date: 12/2020 Categories: Integrative Therapies,Treatment,Ivermectin
Pandemic COVID-19: Current status and challenges of antiviral therapies
https://www.covidstrategies.org/pandemic-covid-19-current-status-and-challenges-of-antiviral-therapies/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340039/ Originally published by: Genes Dis Author: Winglam, et al. Date: 12/7/2020 Categories: Integrative Therapies,Treatment,Ivermectin
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCE
https://www.covidstrategies.org/the-therapeutic-potential-of-ivermectin-for-covid-19-a-systematic-review-of-mechanisms-and-evidence/https://www.medrxiv.org/content/10.1101/2020.11.30.20236570v1.full Originally published by: MedRxIV Author: Kalfas, et al. Date: 12/4/2020 Categories: Integrative Therapies,Treatment,Ivermectin
The use of compassionate Ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the Medical Center Bournigal and the Medical Center Punta Cana, Rescue Group, Dominican Republic, from may 1 to august 10, 2020
https://www.covidstrategies.org/the-use-of-compassionate-ivermectin-in-the-management-of-symptomatic-outpatients-and-hospitalized-patients-with-clinical-diagnosis-of-covid-19-at-the-medical-center-bournigal-and-the-medical-center-pu/https://www.medrxiv.org/content/10.1101/2020.10.29.20222505v1 Originally published by: MedRxiv Author: José Morgenstern, et al. Date: 11/1/2020 Categories: Prevention,Integrative Therapies,Treatment,Ivermectin
Ivermectin in COVID-19: What do we know?
https://www.covidstrategies.org/ivermectin-in-covid-19-what-do-we-know/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521351/ Originally published by: Diabetes Metab Syndr. Author: Pandey S, Pathak SK, Pandey A, et al. Date: 9/28/2020 Categories: Integrative Therapies,Treatment,Ivermectin
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
American Journal of Medicine ~ August 6, 2020 ~ by Dr. Peter McCullough Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection Abstract Approximately 9 months of the severe acute respiratory syndrome coronavius-2...
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
https://www.covidstrategies.org/the-impact-of-the-covid-19-pandemic-on-cancer-deaths-due-to-delays-in-diagnosis-in-england-uk-a-national-population-based-modelling-study/https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30388-0/fulltext Originally published by: The Lancet Author: Camille Maringe, et al. Date: 7/20/2020 Categories: Integrative Therapies,Treatment,Ivermectin
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
https://www.covidstrategies.org/ivermectin-a-systematic-review-from-antiviral-effects-to-covid-19-complementary-regimen/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290143/ Originally published by: The Journal of Antibiotics. Author: Heidary F, Gharebaghi R Date: July 2020 Categories: Integrative Therapies,Treatment, Ivermectin
POST-ACUTE OR PROLONGED COVID-19: IVERMECTIN TREATMENT FOR PATIENTS WITH PERSISTENT SYMPTOMS OR POST-ACUTE
https://www.covidstrategies.org/post-acute-or-prolonged-covid-19-ivermectin-treatment-for-patients-with-persistent-symptoms-or-post-acute/https://www.researchgate.net/publication/344318845_POST-ACUTE_OR_PROLONGED_COVID-19_IVERMECTIN_TREATMENT_FOR_PATIENTS_WITH_PERSISTENT_SYMPTOMS_OR_POST-ACUTE Originally published by: ResearchGate Author: Gustavo Aguirre Chang, et al. Date: 7/1/2020 Categories:...
Ivermectin: potential candidate for the treatment of Covid 19
https://www.covidstrategies.org/ivermectin-potential-candidate-for-the-treatment-of-covid-19/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321032/ Originally published by: Braz J Infect Dis Author: Gupta, et al. Date: 7/1/2020 Categories: Integrative Therapies,Treatment,Ivermectin